Serum TK1 levels have been proposed as a potential marker for the presence of prostate cancer in a few prior investigations and has been investigated as a monitoring and prognostic marker in leukemia, Hodgkin and non-Hodgkin lymphomas4,6. This evidence concerns the gene TK1 and Familial prostate cancer.